Rendiatech

Real-time Renal Diagnostics

Health Tech & Life Sciences
Acquired by Nuwellis
Acquired Jerusalem, Israel Founded 2009
LinkedIn
Last updated 2026-06-18
Total raised
$29.8M
Last: 2021-11
Stage
Acquired
Founded
2009
Headcount
9
HQ
Jerusalem, Israel
Sector
Health Tech & Life Sciences

About

Rendiatech is a medical device company dedicated to real-time renal diagnostics. The company’s first commercially available product, Clarity RMS, is a critical care monitoring system that has been clinically proven to facilitate early detection of changes in renal function and acute kidney injury (AKI) risk, in addition to treatment monitoring.

Clarity RMS provides continuous, automatic monitoring of urine flow, enabling better patient care and ICU economics. It also provides additional real-time parameters and expanded diagnostic capabilities to further improve critical care management in the ICU and perioperative setting.

The Clarity RMS system has FDA clearance as well as CE certification and is installed in tens of general and cardiovascular operating rooms, ICUs, and transplant and COVID-19 units in leading medical centers in the U.S., Europe, and Israel. Future sensor-based products will aim to provide additional diagnostic data about renal and other vital organ function beyond the critical care setting.

Funding history · 5 rounds · $29.8M total

2021-11
2019-05
2018-01
$10.0M
2014-03
$4.0M
2011-01
$1.0M

Q&A

What is Rendiatech's primary business?
Rendiatech is a medical device company focused on real-time renal diagnostics. Their main product, Clarity RMS, is a critical care monitoring system designed for early detection of changes in renal function and acute kidney injury (AKI) risk.
When was Rendiatech acquired and by whom?
Rendiatech was acquired by Nuwellis in August 2025.
What is the status of Rendiatech's Clarity RMS product?
The Clarity RMS system has received FDA clearance and CE certification. It is currently installed in operating rooms, ICUs, and transplant and COVID-19 units in medical centers across the U.S., Europe, and Israel.
What was Rendiatech's most recent funding round?
Rendiatech raised $14,000,000 in November 2021, with BlueRed Partners as a lead investor.
How much total funding has Rendiatech raised?
Rendiatech has raised a total of $29,828,000 across multiple funding rounds.
How many employees does Rendiatech have?
Rendiatech has 1-10 employees.
Who are the co-founders of Rendiatech?
Rendiatech was co-founded by Avi Kleiman, who serves as CEO, and Mor Grinstein, who is no longer with the company.
What technologies does Rendiatech utilize?
Rendiatech utilizes Artificial Intelligence, Machine Learning, and Sensing technologies in its products.

Team · 2

Founder · Co-founder & CEO
LinkedIn ↗
Founder · Co-founder (No longer with the company)
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesDiagnostics DevicesMedical Monitors
Technologies
Artificial IntelligenceMachine LearningSensing
Target customers
Healthcare & Life SciencesHealthcarePatientsProviders
Business model
B2BB2B2C

Highlights

1 PatentsVerified

Tags

early-detectionsensorsnephrologymedical-devicesreal-timediagnosticspreventionmonitoringhospitalsmedical-technologiesnon-invasive
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

LinkedInlinkedin.com/company/10424427

Identifiers & details

Founded2009-6
Employees (exact)9
OfficesBrookline
Status reasonAcquired by Nuwellis on Aug, 2025

Acquisitions & public offerings

Acquired by Nuwellis 2025-08